APLA Profile

Description

1. Anti-Phospholipid IgG

• What It Is: Measures IgG antibodies that target phospholipids, which are essential components of cell membranes.
• Significance: High levels may indicate the presence of autoimmune diseases like antiphospholipid syndrome (APS).
• Why It Matters: APS can cause abnormal blood clotting, leading to conditions such as deep vein thrombosis, stroke, or complications during pregnancy.

2. Anti-Phospholipid IgM

• What It Is: Detects IgM antibodies that attack phospholipids.
• Significance: Elevated IgM levels are an early indicator of autoimmune activity.
• Why It Matters: High IgM levels can increase the risk of blood clots and may signal APS or lupus.

3. Anti-Cardiolipin IgG

• What It Is: Measures IgG antibodies against cardiolipin, a specific type of phospholipid involved in blood clotting.
• Significance: Increased IgG levels are a diagnostic marker for APS.
• Why It Matters: Persistent elevation can lead to arterial or venous thrombosis, miscarriage, or even stroke.

4. Anti-Cardiolipin IgM

• What It Is: Detects IgM antibodies targeting cardiolipin.
• Significance: High levels are associated with early stages of APS or other clotting disorders.
• Why It Matters: This test helps identify individuals at risk of clotting issues, even before symptoms appear.

5. Beta-2 Glycoprotein IgG

• What It Is: Detects IgG antibodies against beta-2 glycoprotein, a protein that interacts with phospholipids to regulate blood clotting.
• Significance: High levels are a key diagnostic criterion for APS.
• Why It Matters: Elevated levels can cause abnormal clotting, resulting in deep vein thrombosis, pulmonary embolism, or recurrent miscarriages.

6. Beta-2 Glycoprotein IgM

• What It Is: Measures IgM antibodies against beta-2 glycoprotein.
• Significance: Elevated levels indicate a possible autoimmune response targeting blood clot regulation.
• Why It Matters: This test can help detect APS or other clotting-related disorders in their early stages. **Why It Matters:** Early detection of APS or other clotting-related disorders is crucial, and this test aids in identifying them at an early stage.